Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Other Operating Expenses (2020 - 2023)

Historic Other Operating Expenses for SELLAS Life Sciences (SLS) over the last 4 years, with Q1 2023 value amounting to $184000.0.

  • SELLAS Life Sciences' Other Operating Expenses rose 214444.44% to $184000.0 in Q1 2023 from the same period last year, while for Dec 2023 it was $184000.0, marking a year-over-year decrease of 4320.99%. This contributed to the annual value of $10.1 million for FY2022, which is 7118.64% up from last year.
  • Latest data reveals that SELLAS Life Sciences reported Other Operating Expenses of $184000.0 as of Q1 2023, which was up 214444.44% from $124000.0 recorded in Q3 2022.
  • SELLAS Life Sciences' Other Operating Expenses' 5-year high stood at $5.7 million during Q4 2021, with a 5-year trough of -$160000.0 in Q2 2021.
  • Moreover, its 4-year median value for Other Operating Expenses was -$9000.0 (2022), whereas its average is $505818.2.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first crashed by 66842.11% in 2021, then skyrocketed by 214444.44% in 2023.
  • Quarter analysis of 4 years shows SELLAS Life Sciences' Other Operating Expenses stood at $19000.0 in 2020, then soared by 29900.0% to $5.7 million in 2021, then plummeted by 97.82% to $124000.0 in 2022, then surged by 48.39% to $184000.0 in 2023.
  • Its last three reported values are $184000.0 in Q1 2023, $124000.0 for Q3 2022, and $209000.0 during Q2 2022.